Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
anticoagulant, complications of
anticoagulant, self-monitoring
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation clinic
artificial intelligence
atrial fibrillation
atrial fibrillation, risk stratification
cerebrovascular accident
cerebrovascular accident, prevention of
cerebrovascular accident, severity
CHADS-VaSC score
compliance
complications
computers, medicine and
controversies in neurology
coumarin
dabigatran
dabigatran, dose
efficacy
factor Xa inhibitor
HAS-BLED score
heart valve, prosthetic
hemorrhagic diathesis
INR value, time in range
INR values
intracerebral hemorrhage
laboratory values, normal
medical app
microhemorrhage, intracerebral
mortality
non-vitamin K antagonist oral anticoagulants
patient information and support
platelet inhibiting drugs
point of care
practice guidelines
prevention of neurologic disorders
quality of life
RELY trial
review article
safety
self monitoring
smartphone
treatment of neurologic disorder
Showing articles 500 to 550 of 1113 << Previous Next >>

Antiplatelet Therapy for Preventing Stroke and Other Vascular Events After Carotid Endarterectomy
Stroke 35:1227-1228, Engelter,S. &Lyrer,P., 2004

Antiplatelet Drug Discontinuation is a Risk Factor for Ischemic Stroke
Neurol 62:1187-1189, Sibon,I. &Orgogozo,J-M., 2004

Direct Thrombin Inhibition
Stroke 35:1519-1522, Elkind,M.S.V. &Sacco,R.L., 2004

Aspriin and Clopidogrel Compared with Colpidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:331-337, Diener,H.-C.,et al, 2004

Routine Use of Gradient-Echo MRI to Screen for Cerebral Amyloid Angiopathy in Elderly Patients
AJR 182:1547-1550, Walker,D.A., et al, 2004

Anticoagulants for Preventing Stroke in Patients with Nonrheumatic Atrial Fibrillation and a History of Stroke or Transient Ischemic Attack
Stroke 35:1782-1783, Saxena,R. &Koudstaal,P.J., 2004

Perioperative Management of Patients Receiving Oral Anticoagulants: A Systematic Review
Arch Int Med 163:901-908, Dunn,A.S. &Turpie,A.G.G., 2003

Risks and Benefits of Anticoagulant and Antiplatelet Medication Use Before Cataract Surgery
Ophthalmology 110:1784-1788, Katz,J.,et al, 2003

Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage, A Systematic Review
Stroke 34:2285-2289, Mees,S.M.D.,et al, 2003

Should I Start All My Ischaemic Stroke and TIA Patients on a Statin, an ACE Inhibitor, a Diuretic, and Aspirin Today?
JNNP 74:1461-1464, Sandercock,P.A.G., 2003

Continuation of Medically Necessary Aspirin and Warfarin During Cutaneous Surgery
Mayo Clin Proc 78:1392-1396, Otley,C.C., 2003

Stroke
Lancet 362:1211-1224, Warlow,C.,et al, 2003

Stroke Risk in Anticoagulated Patients with Atrial Fibrillation Undergoing Endoscopy
Neurol 61:964-968, Blacker,D.J.,et al, 2003

The Medial Brachial Fascial Compartment Syndrome Following Axillary Arteriography
Neurol 61:1037-1041, Tsao,B.E. &Wilbourn,A.J., 2003

A 50-Year-Old Woman With Atrial Fibrillation
JAMA 290:2182-2189, Singer,D.E., 2003

Anticoagulation or Inferior Vena Cava Filter Placement for Patients with Primary Intracerebral Hemorrhage Developing Venous Thromboembolism?
Stroke 34:2999-3005, Kelly,J.,et al, 2003

Stroke Prevention with the Oral Direct Thrombin Inhibitor Ximelagatran Compared with Warfarin in Patients with Non-Valvular Atrial Fibrillation (SPORTIF III): Randomised Controlled Trial
Lancet 362:1691-1698,1686, Executive Steering Committee on Behalf of the SPOR, 2003

10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003

Knowledge and Management of Transient Ischemic Attacks Among US Primary Care Physicians
Neurol 61:1455-1456, Nguyen-Huynh,M.N.,et al, 2003

Resolved: Heparin May Be Useful in Selected Patients with Brain Ischemia
Stroke 34:230-231, Caplan,L.R., 2003

Asymptomatic Microbleeds as a Risk Factor for Aspirin-Associated Intracerebral Hemorrhages
Neurol 60:511-513, Wong,K.S.,et al, 2003

Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Further Vascular Events After Transient Ischemic Attack or Minor Stroke of Presumed Arterial Origin
Stroke 34:234-235, Algra,A.,et al, 2003

Cerebral Venous Thrombosis
Neurol 60:1175-1178, Cakmak,S.,et al, 2003

Guidelines for the Early Management of Patients with Ischemic Stroke
Stroke 34:1056-1083, Adams,H.P.,et al, 2003

Platelet Function Under Aspirin, Clopidogrel, and Both After Ischemic Stroke
Stroke 34:849-855, Grau,A.J.,et al, 2003

Anticoagulation for Cerebral Sinus Thrombosis
Stroke 34:1054-1055, Stam,J.,et al, 2003

Clinical Spectrum of Succinic Semialdehyde Dehydrogenase Deficiency
Neurol 60:1413-1417, Pearl,P.L.,et al, 2003

Oral Anticoagulation in Patients After Cerebral Ischemia of Arterial Origin and Risk of Intracranial Hemorrhage
Stroke 34:e45, ESPRIT, 2003

Cerebral Ischemic Events After Diagnosis of Mitral Valve Prolapse
Stroke 34:1339-1345, Avierinos,J.,et al, 2003

Anticoagulants Versus Antiplatelet Agents for Acute Ischemic Stroke
Stroke 34:1571-1572, Berge,E. &Sandercock,P., 2003

Can Patients be Anticoagulated After Intracerebral Hemorrhage?
Stroke 34:1710-1716, Eckman,M.H.,et al, 2003

Cranial MR Imaging Findigns of Potassium Chlorate Intoxication
AJNR 24:1396-1398, MutluH.,et al, 2003

A Risk Score for Predicting Stroke or Death in Individuals with New-Onset Atrial Fibrillation in the Community
JAMA 290:1049-1056,1093, Wang,T.J.,et al, 2003

Stroke Prevention in Atrial Fibrillation
JAMA 290:1093-1095, Waldo,A.L., 2003

A Clinical Comparison of Non-Traumatic Acute Subdural Haematomas Either Related to Coagulopathy or of Arterial Origin Without Coagulopathy
Acta Neurochir 145:541-546, Depreitere, B.,et al, 2003

Clinical Profile of Stroke in 900 Patients with Hypertrophic Cardiomyopathy
J Am Coll Cardiol 39:301-307, Maron,B.J.,et al, 2002

Antiphospholipid Syndrome and Multiple Ischemic Strokes in a Patient with Myasthenia Gravis
Kurume Med J 49:211-216, Kaji, M.,et al, 2002

Emergent Use of Anticoagulation for Treatment of Patients with Ischemic Stroke
Stroke 33:856-861, Adams,H.P., 2002

Use of Intravenous Heparin by North American Neurologists
Stroke 33:1574-1577, Al-Sadat,A.,et al, 2002

Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial
Stroke 33:1723-1726, Hankey,G.J., 2002

Aspirin Should be First-Line Antiplatelet Therapy in the Secondary Prevention of Stroke
Stroke 33:2137-2139, Warlow,C., 2002

Leukoaraiosis is Associated with Warfarin-Related Hemorrhage Following Ischemic Stroke
Neurol 59:193-197, Smith,E.E.,et al, 2002

Intracerebral Hemorrhages Associated with Neurointerventional Procedures Using a Combination of Antithrombotic Agents Including Abciximab
Stroke 33:1916-1919, Qureshi,A.I.,et al, 2002

Low-Molecular-Weight Heparins or Heparinoids Versus Standard Unfarctionated Heparin for Acute Ischemic Stroke (Cochrane Review)
Stroke 33:1925-1926, Counsell,C. &Sandercock,P., 2002

Considering the Role of Heparin and Low-Molecular-Weight Heparins in Acute Ischemic Stroke
Stroke 33:1927-1933, Moonis,M. &Fisher,M., 2002

Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke
Neurol 59:13-22, Coull,B.M.,et al, 2002

Transoesophageal Echocardiography in Selecting Patients for Anticoagulation After Ischaemic Stroke or Transient Ischaemic Attack
JNNP 73:29-33, Strandberg,M.,et al, 2002

MR Changes after Acute Cyanide Intoxication
AJNR 23:1398-1401, Rachinger,J.,et al, 2002

Delayed Neuropathy and Myelopathy After Organophosphate Intoxication
NEJM 347:1119-1121, Chuang,C.,et al, 2002

New Evidence for Stroke Prevention
JAMA 288:1396-1398, Straus,S.E.,et al, 2002



Showing articles 500 to 550 of 1113 << Previous Next >>